Free Trial

Natural Alternatives International (NAII) Competitors

Natural Alternatives International logo
$3.44 +0.01 (+0.29%)
As of 07/10/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NAII vs. PLRX, ZURA, EPIX, QNCX, SRZN, INCR, IMMX, ABOS, IMUX, and GNTA

Should you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include Pliant Therapeutics (PLRX), Zura Bio (ZURA), ESSA Pharma (EPIX), Quince Therapeutics (QNCX), Surrozen (SRZN), InterCure (INCR), Immix Biopharma (IMMX), Acumen Pharmaceuticals (ABOS), Immunic (IMUX), and Genenta Science (GNTA). These companies are all part of the "pharmaceutical products" industry.

Natural Alternatives International vs. Its Competitors

Natural Alternatives International (NASDAQ:NAII) and Pliant Therapeutics (NASDAQ:PLRX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

In the previous week, Pliant Therapeutics had 1 more articles in the media than Natural Alternatives International. MarketBeat recorded 2 mentions for Pliant Therapeutics and 1 mentions for Natural Alternatives International. Pliant Therapeutics' average media sentiment score of 1.73 beat Natural Alternatives International's score of 0.00 indicating that Pliant Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Natural Alternatives International Neutral
Pliant Therapeutics Very Positive

32.4% of Natural Alternatives International shares are held by institutional investors. Comparatively, 97.3% of Pliant Therapeutics shares are held by institutional investors. 20.9% of Natural Alternatives International shares are held by company insiders. Comparatively, 8.0% of Pliant Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Pliant Therapeutics has a net margin of 0.00% compared to Natural Alternatives International's net margin of -6.56%. Natural Alternatives International's return on equity of -10.34% beat Pliant Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Natural Alternatives International-6.56% -10.34% -5.19%
Pliant Therapeutics N/A -67.56%-52.54%

Natural Alternatives International has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500. Comparatively, Pliant Therapeutics has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500.

Pliant Therapeutics has a consensus price target of $13.31, suggesting a potential upside of 850.89%. Given Pliant Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Pliant Therapeutics is more favorable than Natural Alternatives International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natural Alternatives International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Pliant Therapeutics
0 Sell rating(s)
12 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Natural Alternatives International has higher revenue and earnings than Pliant Therapeutics. Natural Alternatives International is trading at a lower price-to-earnings ratio than Pliant Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Natural Alternatives International$125.48M0.17-$7.22M-$1.39-2.52
Pliant Therapeutics$1.58M54.40-$210.30M-$3.61-0.39

Summary

Pliant Therapeutics beats Natural Alternatives International on 9 of the 15 factors compared between the two stocks.

Get Natural Alternatives International News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAII vs. The Competition

MetricNatural Alternatives InternationalMED IndustryMedical SectorNASDAQ Exchange
Market Cap$21.63M$2.43B$5.55B$9.02B
Dividend YieldN/A1.79%5.25%4.04%
P/E Ratio-2.529.3827.1820.14
Price / Sales0.17483.65379.4880.15
Price / CashN/A164.1737.5058.41
Price / Book0.264.698.075.60
Net Income-$7.22M$31.26M$3.16B$248.43M
7 Day Performance9.03%6.81%4.71%5.47%
1 Month Performance2.34%5.93%4.52%7.87%
1 Year Performance-38.60%-1.03%30.82%18.75%

Natural Alternatives International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAII
Natural Alternatives International
0.4205 of 5 stars
$3.50
+2.0%
N/A-38.8%$21.63M$125.48M-2.52290Gap Down
PLRX
Pliant Therapeutics
4.4056 of 5 stars
$1.18
-6.3%
$13.31
+1,028.2%
-87.4%$77.35M$1.58M-0.3390News Coverage
Positive News
ZURA
Zura Bio
2.4572 of 5 stars
$1.10
-2.7%
$14.33
+1,203.0%
-61.9%$77.26MN/A-1.573News Coverage
Positive News
Gap Up
EPIX
ESSA Pharma
1.3625 of 5 stars
$1.70
-2.3%
$2.00
+17.6%
-66.6%$77.24MN/A-2.7050Positive News
QNCX
Quince Therapeutics
3.1776 of 5 stars
$1.63
+1.2%
$8.00
+390.8%
+147.2%$73.21MN/A-1.1760
SRZN
Surrozen
2.275 of 5 stars
$8.35
-0.1%
$38.50
+361.1%
-11.4%$71.58M$10.65M-0.3380
INCR
InterCure
0.497 of 5 stars
$1.50
-3.8%
N/A-30.2%$71.09M$238.85M0.00350High Trading Volume
IMMX
Immix Biopharma
3.6563 of 5 stars
$2.62
+2.7%
$7.00
+167.2%
+32.8%$71.09MN/A-3.749
ABOS
Acumen Pharmaceuticals
1.7954 of 5 stars
$1.16
flat
$6.33
+446.0%
-43.2%$70.26MN/A-0.6020News Coverage
Positive News
IMUX
Immunic
2.6728 of 5 stars
$0.77
+5.2%
$11.60
+1,416.3%
-34.4%$69.68MN/A-0.6270
GNTA
Genenta Science
1.9271 of 5 stars
$3.98
+4.7%
$25.00
+528.1%
+33.1%$69.50MN/A0.007News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:NAII) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners